- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-520/23: Action brought on 22 August 2023 — Hecht Pharma v EUIPO — Gufic BioSciences (H 15 Gufic H 15 Gufic)
ECLI:EU:UNKNOWN:62023TN0520
62023TN0520
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
Series C
C/2023/69
9.10.2023
(Case T-520/23)
(C/2023/69)
Language in which the application was lodged: German
Parties
Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)
Defendant: European Union Intellectual Property Office
Other party to the proceedings before the Board of Appeal: Gufic BioSciences Ltd. (Mumbai, India)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: EU figurative mark H 15 Gufic H 15 Gufic — EU trade mark No 8 285 661
Proceedings before EUIPO: Cancellation proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 13 June 2023 in Case R 902/2021-2
Form of order sought
The applicant claims that the Court should:
—annul the contested decision and declare the trade mark at issue to be revoked also in respect of Class 5 ‘Medicines’;
—order EUIPO to pay the costs of the appeal proceedings and of the pre-litigation procedure.
Plea in law
—Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
ELI: http://data.europa.eu/eli/C/2023/69/oj
ISSN 1977-091X (electronic edition)